Skip to main content

BC Cancer – Abbotsford

If you are interested in more information about a particular trial, please talk with your treating physician first, and they may contact this centre for further information if necessary.

Tumour Group / SiteTrial TitleOpening Date
Breast
Assessment of breast cancer and response to systemic therapy before surgery using diffuse optical imaging technology. (DOB-Scan)
August 2018
GastrointestinalA Phase 3, randomized, double-blind clinical study of pembrolizumab (MK-3475) plus chemotherapy versus placebo plus chemotherapy as first-line treatment in participants with HER2 negative, previously untreated, unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (KEYNOTE-859).
Mar. 26, 2019
Melanoma
A Phase 3, randomized, open-label study of NKTR-214 combined with Nivolumab versus Nivolumab in participants with previously untreated unresectable or metastastic melanoma (SMTCA045).
Nov.18, 2020

SOURCE: BC Cancer – Abbotsford ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2021 Provincial Health Services Authority